BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28634666)

  • 1. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
    Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer.
    Fukui H; Hori M; Fukuda Y; Onishi H; Nakamoto A; Ota T; Ogawa K; Ninomiya K; Tatsumi M; Osuga K; Yamada D; Eguchi H; Miyoshi E; Tomiyama N
    Eur J Radiol; 2019 Sep; 118():25-31. PubMed ID: 31439250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT.
    Zhu L; Dai MH; Wang ST; Jin ZY; Wang Q; Denecke T; Hamm B; Xue HD
    Eur J Radiol; 2018 Aug; 105():8-14. PubMed ID: 30017302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
    Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
    AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 7. CT texture analysis for the presurgical prediction of superior mesenteric-portal vein invasion in pancreatic ductal adenocarcinoma: comparison with CT imaging features.
    Chen F; Zhou Y; Qi X; Xia W; Zhang R; Zhang J; Gao X; Zhang L
    Clin Radiol; 2021 May; 76(5):358-366. PubMed ID: 33581837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study.
    Napoleon B; Alvarez-Sanchez MV; Gincoul R; Pujol B; Lefort C; Lepilliez V; Labadie M; Souquet JC; Queneau PE; Scoazec JY; Chayvialle JA; Ponchon T
    Endoscopy; 2010 Jul; 42(7):564-70. PubMed ID: 20593334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel preoperative predictor of pancreatic fistula using computed tomography after distal pancreatectomy with staple closure.
    Fukuda Y; Yamada D; Eguchi H; Iwagami Y; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Mori M; Doki Y
    Surg Today; 2017 Oct; 47(10):1180-1187. PubMed ID: 28265770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations.
    Ma C; Li Y; Wang L; Wang Y; Zhang Y; Wang H; Chen S; Lu J
    Cancer Imaging; 2017 Apr; 17(1):12. PubMed ID: 28454564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
    Aslan S; Nural MS; Camlidag I; Danaci M
    Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
    Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
    Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of virtual touch quantification in the diagnosis of pancreatic ductal adenocarcinoma.
    Onoyama T; Koda M; Fujise Y; Takata T; Kawata S; Okamoto T; Miyoshi K; Matono T; Sugihara T; Matsumoto K; Kawaguchi K; Harada K; Yashima K; Isomoto H
    Clin Imaging; 2017; 42():64-67. PubMed ID: 27886609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
    Pancreas; 2019; 48(10):1360-1366. PubMed ID: 31688602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis.
    Eilaghi A; Baig S; Zhang Y; Zhang J; Karanicolas P; Gallinger S; Khalvati F; Haider MA
    BMC Med Imaging; 2017 Jun; 17(1):38. PubMed ID: 28629416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.